Search alternatives:
recombinant patients » recombinant antigens (Expand search), recombinant variant (Expand search), recombinant antivenoms (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
patients decrease » patients case (Expand search), patients diseases (Expand search), statins decrease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease toc » decrease of (Expand search), decrease the (Expand search), decrease on (Expand search)
toc decrease » to decrease (Expand search), the decrease (Expand search), not decrease (Expand search)
recombinant patients » recombinant antigens (Expand search), recombinant variant (Expand search), recombinant antivenoms (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
patients decrease » patients case (Expand search), patients diseases (Expand search), statins decrease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease toc » decrease of (Expand search), decrease the (Expand search), decrease on (Expand search)
toc decrease » to decrease (Expand search), the decrease (Expand search), not decrease (Expand search)
1
2
“.... Concerning to iron status, patients showed increased ferritin and prohepcidin serum levels, and a decrease...”
Access document
Access document
Article
3
4
“... after interferon-a was achieved in 44 patients. We have classified the serum ALT responses into six...”
Access document
Access document
Article
5
6
7
“...) levels. Conclusion CKD patients under hemodialysis present with raised inflammatory markers and decrease...”
Access document
Access document
Article
8
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
“... of insoluble SNCA after treatment with rHsCTSD. Moreover, we demonstrate a decrease of pathological SNCA...”Access document
Article
9
10
11
12
13
“... (AD), a neurodegenerative disorder affecting millions of people around the world. MiRNA-29 plays a crucial role in processes...”
Access document
Access document
14
15
16
“...A group of 50 patients (26 men and 24 women, mean age 50 +/- 19 years and range...”
Access document
Access document
Article
17
18
19
20